NEWRON PHARMACEUTICALS SPA (NP5.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:NP5 - IT0004147952 - Common Stock
26.35 EUR
+0.25 (+0.96%)
ChartMill assigns a Buy % Consensus number of 85% to NP5.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 20.09. This target is -23.75% below the current price.
NP5.DE was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about NP5.DE.
In the previous month the buy percentage consensus was at a similar level.
NP5.DE was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
NEWRON PHARMACEUTICALS SPA / NP5.DE FAQ
What do analysts expect the price target to be for NEWRON PHARMACEUTICALS SPA (NP5.DE)?
8 analysts have analysed NP5.DE and the average price target is 20.09 EUR. This implies a price decrease of -23.75% is expected in the next year compared to the current price of 26.35.
How do analysts rate NEWRON PHARMACEUTICALS SPA (NP5.DE)?
The consensus rating for NEWRON PHARMACEUTICALS SPA (NP5.DE) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.